CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleLevered free cash flow is -$3.11B, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 7.44: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
13.24BCNY1.96B · vs all stocks (USD)
Trailing P/E
0.4349xRevenue (TTM)
6.37BCNY944.84M · vs all stocks (USD)
Profit Margin
485.00%Beta
1.31xvs all stocks
52-Week Change
-8.09%vs all stocks
Market Capitalization
13.24BCNY1.96B · vs all stocks (USD)
Enterprise Value
13.54BCNY2.01B · vs all stocks (USD)
Trailing P/E
0.4349xForward P/E
2.35xPrice to Sales (TTM)
2.11xPrice to Book (MRQ)
3.26xEnterprise to Revenue
2.13xEnterprise to EBITDA
-45.97xGross Margin
13.74%Profit Margin
485.00%Operating Margin
-6.86%Return on Assets (TTM)
-18.64%Return on Equity (TTM)
614.57%Revenue (TTM)
6.37BCNY944.84M · vs all stocks (USD)
Revenue per Share (TTM)
0.6050CNYUpdated Aug 18, 2026Quarterly Revenue Growth
-68.10%Gross Profit (TTM)
-21.95BCNY-3.26B · vs all stocks (USD)
EBITDA (TTM)
62.39BCNY9.25B · vs all stocks (USD)
Net Income (TTM)
30.90BCNY4.58B · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-95.99%Operating Cash Flow (TTM)
-1.54BCNY-227.82M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-21.00BCNY-3.11B · vs all stocks (USD)
5-Year Average Dividend Yield
6.26%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
615.21MCNYFY2025 · Dec 31, 2025Revenue
6.88BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
5.91BCNYFY2025 · Dec 31, 2025Gross Profit
978.65MCNYFY2025 · Dec 31, 2025Operating Income
-604.10MCNY-89.59M · vs all stocks (USD)
Pre-tax Income
27.65BCNYFY2025 · Dec 31, 2025Income Tax Expense
2.87BCNYFY2025 · Dec 31, 2025Net Income
24.77BCNYFY2025 · Dec 31, 2025EBIT
33.18BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
62.39BCNYFY2025 · Dec 31, 2025Selling, General & Administrative
311.55MCNYFY2025 · Dec 31, 2025Other Operating Expenses
892.92MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
238.86MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
5.54BCNYFY2025 · Dec 31, 2025EPS (Basic)
2.77CNYFY2025 · Dec 31, 2025EPS (Diluted)
2.77CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
10.59BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
10.59BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
24.77BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
4.55BCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
34.48BCNYFY2025 · Dec 31, 2025Free Cash Flow
34.47BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.10BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
24.77BCNYFY2025 · Dec 31, 2025Other Non-cash Items
5.55BCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-1.06BCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
5.22BCNYFY2025 · Dec 31, 2025Capital Expenditures
-12.87MCNYFY2025 · Dec 31, 2025Net Acquisitions
209.32KCNYFY2025 · Dec 31, 2025Purchase of Investments
-57.87MCNYFY2025 · Dec 31, 2025Sale of Investments
34.77MCNYFY2025 · Dec 31, 2025Other Investing Activity
-537.43MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-573.18MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
127.41MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-667.61MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-241.56MCNYFY2025 · Dec 31, 2025Other Financing Charges
2.96BCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
2.18BCNYFY2025 · Dec 31, 2025Shares Outstanding
10.63BSharesUpdated Aug 18, 2026Float Shares
9.81BSharesUpdated Aug 18, 2026% Held by Insiders
21.12%vs all stocks
% Held by Institutions
6.28%vs all stocks
Total Cash (MRQ)
1.24BCNY184.22M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.1170CNYUpdated Aug 18, 2026Total Debt (MRQ)
746.50MCNY110.71M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1587xCurrent Ratio (MRQ)
1.98xBook Value per Share (MRQ)
0.3890CNYUpdated Aug 18, 2026Total Assets
14.89BCNY2.21B · vs all stocks (USD)
Total Current Assets
9.62BCNYFY2025 · Dec 31, 2025Total Liabilities
10.12BCNYFY2025 · Dec 31, 2025Total Non-current Assets
5.27BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
5.15BCNYFY2025 · Dec 31, 2025Total Current Liabilities
4.97BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.41BCNYFY2025 · Dec 31, 2025Other Short-term Investments
56.93MCNYFY2025 · Dec 31, 2025Accounts Receivable
72.03MCNYFY2025 · Dec 31, 2025Inventory
2.44BCNYFY2025 · Dec 31, 2025Accounts Payable
1.24BCNYFY2025 · Dec 31, 2025Short-term Debt
685.96MCNYFY2025 · Dec 31, 2025Other Current Liabilities
36.70MCNYFY2025 · Dec 31, 2025Long-term Debt
59.98MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
204.59MCNYFY2025 · Dec 31, 2025Common Stock (Book)
10.63BCNYFY2025 · Dec 31, 2025Retained Earnings
-16.32BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.77BCNY707.62M · vs all stocks (USD)
Treasury Stock
264.97MCNYFY2025 · Dec 31, 202552-Week Low
1.04CNYUpdated Aug 18, 202652-Week High
1.58CNYUpdated Aug 18, 202652-Week Change
-8.09%vs all stocks
Beta
1.31xvs all stocks
50-Day MA
1.26CNYUpdated Aug 18, 2026200-Day MA
1.39CNYUpdated Aug 18, 2026Avg 10-Day Volume
222.13MSharesUpdated Aug 18, 2026Avg 30-Day Volume
247.75MSharesUpdated Aug 18, 2026Diluted EPS (TTM)
2.92CNYUpdated Aug 18, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 4,582,450,675.917Operating Cash Flow (USD, TTM): -227,815,071.642
Financial Health
Altman Z-Score 7.44: safe zoneNotable
Altman Z-Score: 7.44
High earnings qualityNotable
Earnings Quality Score: 0.54
High structural barrier to entryNotable
Barrier to Entry: 3.45
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Levered free cash flow is -$3.11B, lower than 95% of all stocks globallySignificant
Levered free cash flow (USD): -3,114,139,560.755Global P5: -219,013,500
Market cap is $1.96B, above the global median of $1.15BNotable
Market cap (USD): 1,962,886,126.282Global Median: 1,146,734,693.424
Revenue is $944.84M, above the global median of $520.53MNotable
Revenue (USD): 944,837,570.56Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Auntea Jenny (Shanghai) Industrial Co., Ltd.
Tier 1ProductionUnit ReplicationRuleInterface
Brigade Enterprises Ltd.
Tier 1ProductionUnit ReplicationRiskRule
Hanwha Vision Co., Ltd.
Tier 1ProductionUnit ReplicationRuleFlow
Nanjing Gaoke Co. Ltd.
Tier 1ProductionUnit ReplicationRiskRule
Sunac China Holdings Ltd.
Tier 1ProductionUnit ReplicationRiskRule
Xtep International Holdings Limited
Tier 1ProductionUnit ReplicationRiskInterface
Guzman y Gomez Limited
Tier 1ProductionUnit ReplicationRuleFlow
Shenzhen Heungkong Holding Co., Ltd.
Tier 1ProductionUnit ReplicationRisk
Century Communities, Inc.
Tier 1ProductionUnit ReplicationRiskRule
Metrovacesa S.A.
Tier 1ProductionUnit ReplicationRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Hubei Jumpcan Pharmaceutical Co., Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
CIE Automotive India Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Manhattan Associates Inc.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities